Bpa Los Angeles
Posted : admin On 4/5/2022Chemical Measured by Biomonitoring California Bisphenol A (BPA) is used to make a hard plastic called polycarbonate. Until recently, BPA was also widely used to make the protective coatings inside food and drink cans, but US manufacturers have been phasing it out in response to consumer demand and scientific findings of serious health concerns. Bottles Wholesale Manufacturers in Los Angeles on YP.com. See reviews, photos, directions, phone numbers and more for the best Bottles-Wholesale & Manufacturers in Los Angeles, CA.
BPA Worldwide is a US-based company that provides independent, third-party audits of audience claims of business-to-business and consumer media and events. Its membership includes magaziness, newspapers, web sites, events, email newsletters, digital magazines and other advertiser-supported media produced by its members. The company is a not-for-profit, (501(c)(6) organization, and is one of the largest auditor of media in the world in terms of membership, which consists of media owners, marketer companies and advertising agencies.[citation needed] In addition to its US headquarters, BPA operates offices in Canada, UK, China and the Middle East.
History[edit]
In 1931, Controlled Circulation Audit Inc (CCA) opened in New York City. Their first audit, Drug Topics, was completed in September of that year.
In 1954, the CCA changed its name to BPA, which at the time stood for Business Publications Audit of Circulation, Inc. In the same year that they opened their first satellite office in Chicago, Illinois. In 1970 BPA completed its first audit of a European title, Vision.
In 1980, the first audit of pass-along individuals was conducted for Architectural Record. This report used surveys to qualified subscribers to determine how many additional individuals also read their copy of the publication.
In 1985, BPA opened their West Coast office in Los Angeles, California.
In 1995, BPA was changed to BPA International with the addition of their first overseas office in London. In 1998, the Canadian Circulations Audit Board (CCAB) merged with BPA International. With the addition of their audited titles, total media owner membership exceeded 2,500 members and 500 employees.
In 2004, BPA International changed its name to BPA Worldwide. This coincided with the opening of an office in Beijing, China. In 2006, BPA opened an office in Dubai Media City.
BPA launched its Brand Report product in 2008. The statement reports all of a media owner's audience 'touch points' on a single statement.[1]
In 2012, BPA opened a branch office in Shenzhen, Guangdong Province in China.[2] BPA opened another office in Hong Kong in March 2001.
BPA Worldwide currently performs nearly 2,600 audits in over 20 countries.
The BPA Media Exchange was launched in 2017 to help publishers deploy media solutions in an evolving digital marketplace.[3] Publishers and advertisers may transact through the Media Exchange via both direct- and indirect sales activation.
BPA is led by CEO and President Glenn Hansen.
References[edit]
- ^https://www.foliomag.com/bpa-redesigns-shifts-exclusively-brand-report-format/
- ^https://www.exhibitoronline.com/news/article.asp?ID=10686
- ^https://www.mediapost.com/publications/article/294562/bpa-worldwide-will-launch-b2b-private-marketplace.html
What is a Balloon Pulmonary Angioplasty (BPA)?
Balloon Pulmonary Angioplasty (BPA) is a minimally invasive treatment for certain patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH). The basic principal is that by dilating the pulmonary arteries pulmonary perfusion and pressures may be improved, as a minimally invasive treatment option in patients who are not candidates for PTE. Dr. John Moriarty, who performs the BPA procedure at UCLA, is a nationally known interventional radiologist who is among a small group of experts in the world performing BPA.
Treatment Planning
All patients are evaluated by the UCLA Pulmonary Vascular Disease Team, including including Pulmonologists, Cardiothoracic surgeons and Interventional Radiologists. Comprehensive assessment of the patient including hemodynamic capacity, CT scans, nuclear medicine scans and medication is performed, and then suitable patients will be offered an angiogram. This is a test whereby dye is injected into the pulmonary arteries by a small catheter placed into the vein, and then live Xrays are taken to evaluate the flow and presence of clots and blockages. These images are then carefully reviewed by experts to evaluate whether the patient has “good target lesions” for BPA. If they exist, then the patient will be offered treatment.
BPA Treatment
BPA is a minimally invasive, angiographic, procedure performed by an experienced physician team. It is performed under conscious sedation with additional anesthesia available if required. The vein in the thigh (right common femoral vein) is accessed and then a small catheter inserted. This is then guided through the heart to the pulmonary arteries of the lungs, and a target vessel accessed. Once position and safety is confirmed then the vessel is dilated with a balloon (angioplasty). This allows better flow to the lung, improving oxygenation and decreasing pressure. Frequently multiple areas within one lung are dilated at one time. The procedure usually takes 3-4 hours, and then the patient is transferred to our pulmonology floor for monitoring and care. The patient is monitored for any breathing or bleeding problems (which may rarely occur) and then returns for another procedure the day after with treatment of the other lung. The patient is then monitored and discharged the following day.
Following the set of procedures, the patient is followed in the Pulmonary Vascular Disease Clinic, and frequently will require several treatments of each lung before the BPA treatment cycle is complete.
Results of BPA
Boa Los Angeles Ca
BPA improves pulmonary hemodynamics, as measured by mPAP, cardiac index (CI), PVR, brain natriuretic peptide (BNP), echocardiographic, magnetic resonance imaging and metrics of functional capacity, such as home oxygen requirement, NYHA/WHO functional class and 6MWD BPA also was associated with improved renal function, blood sugar control and nutritional status. These findings persisted after BPA with stable findings at 6 months or greater in various populations. Complications of BPA mostly involve vascular injury and reperfusion pulmonary edema which may manifest immediately or several days post-procedure.